No abstract

Background In populations with high rates of human immunodeficiency virus (HIV)-coinfection, the nature of the relationship between human papillomavirus (HPV)-16 and -18 (L1, E6 and E7) antibodies and cervical cancer is still uncertain. We measured the association between seropositivity to HPV (L1, E6 and E7) proteins and cervical cancer among black South African women with and without HIV co-infection. Methods We used questionnaire data and serum collected from consecutively recruited patients with a newly diagnosed cancer from the Johannesburg Cancer Study from 1346 cervical cancer cases and 2532 controls (diagnosed with other non-infection related cancers). Seropositivity to HPV proteins was measured using a multiplex serological assay based on recombinant glutathione S-transferase (GST) fusion proteins. We measured associations between their presence and cervical cancer using unconditional logistic regression models and evaluated the sensitivity and specificity of these HPV biomarkers. Results Among controls, HIV-negative women from rural areas compared to urban had significantly higher HPV seroprevalence, HPV16 E7 (8.6% vs 3.7%) and HPV18 E7 (7.9% vs 2.0%). HPV16 E6 and E7 antibodies were positively associated with cervical cancer in HIV-positive (Adjusted Odds Ratio (AOR) = 33; 95% CI 10–107) and HIV-negative women (AOR = 97; 95% CI 46–203). In HIV-positive women, HPV E6/E7 antibodies had low sensitivity (43.0%) and high specificity (90.6%) for cervical cancer detection. In HIV-negative women, HPV E6/E7 antibodies sensitivity was 70.6% and specificity was 89.7%. Conclusions Our data show that HPV (L1, especially E6 and E7) antibody positivity is associated with cervical cancer in both HIV-positive and HIV-negative women. Nonetheless, being HIV-positive plays an important role in the development of cervical cancer.

IntroductionEvidence from low-income and middle-income countries suggests that migration status has an impact on health. However, little is known about the effect that migration status has on morbidity in sub-Saharan Africa. The aim of this study is to investigate the association between migration status and hypertension and diabetes and to assess whether the association was modified by demographic and socioeconomic characteristics.MethodsA Quality ofLife survey conducted in 2015 collected data on migration status and morbidity from a sample of 28 007 adults in 508 administrative wards in Gauteng province (GP). Migration status was divided into three groups: non-migrant if born in Gauteng province, internal migrant if born in other South African provinces, and external migrant if born outside of South Africa. Diabetes and hypertension were defined based on self-reported clinical diagnosis. We applied a recently developed original, stepwise-multilevel logistic regression of discriminatory accuracy to investigate the association between migration status and hypertension and diabetes. Potential effect modification by age, sex, race, socioeconomic status (SES) and ward-level deprivation on the association between migration status and morbidities was tested.ResultsMigrants have lower prevalence of diabetes and hypertension. In multilevel models, migrants had lower odds of reporting hypertension than internal migrants (OR=0.86; 95% CI 0.78 to 0.95) and external migrant (OR=0.60; 95% CI 0.49 to 0.75). Being a migrant was also associated with lower diabetes prevalence than being an internal migrant (OR=0.84; 95% CI 0.75 to 0.94) and external migrant (OR=0.53; 95% CI 0.41 to 0.68). Age, race and SES were significant effect modifiers of the association between migration status and morbidities. There was also substantial residual between-ward variance in hypertension and diabetes with median OR of 1.61 and 1.24, respectively.ConclusionsMigration status is associated with prevalence of two non-communicable conditions. The association was modified by age, race and SES. Ward-level effects also explain differences in association.